The global scar treatment market size was estimated at USD 2.85 billion in 2025 and is projected to reach USD 6.45 billion by 2033, growing at a CAGR of 10.6% from 2026 to 2033. The market is expected to grow due to several factors, including the growing concern among people regarding their aesthetic appearance, the increasing number of road accidents and burn injuries, and technological advancements that supplement new device launches.
The rise in elective cosmetic surgeries and minimally invasive procedures has also increased the demand for effective post-procedural scar management. Moreover, the expansion of healthcare access in emerging economies, the influence of social media on beauty standards, and the increasing availability of over-the-counter scar care formulations further contribute to the market’s growth.
One of the major factors driving the market, particularly across topical and laser product segments, is the increasing number of cosmetic and reconstructive procedures performed globally. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2024, approximately 1.6 million cosmetic surgical procedures were performed worldwide. Patients are increasingly seeking post-procedure care options, such as silicone gels, scar creams, and laser therapies, to minimize visible scarring and improve skin texture. Furthermore, laser-based scar revision procedures, including CO2 and pulsed-dye laser treatments, are gaining popularity in dermatology clinics due to their precision and faster healing profiles. This growing procedural volume and higher consumer preference for minimally invasive skin correction and at-home care options propel product demand across clinical and home care end use settings.
Telemedicine is a valuable resource in the management of scar wounds, facilitating the assessment, monitoring, and management of surgical and injury-related scarring remotely. Through teledermatology platforms and mobile applications, patients can upload high-resolution images of their scars or wounds and receive an assessment from a trained clinician with minimal face-to-face visits to the clinic. This strategy enhances access for patients in rural or underserved communities who lack proximate access to either a dermatologist or a plastic surgeon. For instance, an Italian-based study titled "Telemonitoring Wound Recovery with a Smartphone” concluded that a smartphone visit could produce similar outcomes to an in-person visit, while providing an enormous benefit by significantly reducing travel costs and time away from work and family that a face-to-face consultation creates.
The growing number of road accidents is one of the key factors, furthering the demand for scar treatment products. According to the Population Reference Bureau, around 50 million people are injured due to road accidents every year, which frequently leads to the occurrence of scars requiring surgical treatment. Patients who undergo such surgeries develop surgical scars and are provided with topical products to improve and reduce their appearance. Hence, the rising number of road accidents and an increasing number of cosmetic surgeries are expected to propel the need for topical products for scar treatment.
The high prevalence of burn injuries is another driving factor supporting the market's growth. According to the CDC, in the U.S., 1.1 million burn injuries require medical attention every year, and around 50,000 of these people require hospitalization. Burn injuries leave noticeable hypertrophic burn marks, which distort the victim's appearance. Scar removal products are crucial for such injuries. Moreover, post-burn marks hinder victims' routine lifestyles. Plastic surgeries or resurfacing laser therapies are commonly performed to remove these marks, accelerating the growth of scar removal treatment products.
The market is experiencing immense technological developments with the introduction of laser therapy, for instance, MedLite C6, a Q-switched laser-based instrument developed for treating acne. Laser instruments help destroy scar tissue, thereby driving the scar treatment product market. Treatment with laser products involves both surgical and nonsurgical procedures. Plastic and reconstructive surgery is also a part of the surgical laser treatment process. For instance, in April 2025, AVAVA received the U.S. Food and Drug Administration (FDA) 510(k) approval for the treatment of acne scarring across all Fitzpatrick skin types (I-VI). This approval addresses the long-standing challenge of safely treating acne scars in individuals with darker skin tones, expanding access to effective laser therapies, further driving the acne scar treatment market.
This product will be delivered within 1-3 business days.
The rise in elective cosmetic surgeries and minimally invasive procedures has also increased the demand for effective post-procedural scar management. Moreover, the expansion of healthcare access in emerging economies, the influence of social media on beauty standards, and the increasing availability of over-the-counter scar care formulations further contribute to the market’s growth.
One of the major factors driving the market, particularly across topical and laser product segments, is the increasing number of cosmetic and reconstructive procedures performed globally. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2024, approximately 1.6 million cosmetic surgical procedures were performed worldwide. Patients are increasingly seeking post-procedure care options, such as silicone gels, scar creams, and laser therapies, to minimize visible scarring and improve skin texture. Furthermore, laser-based scar revision procedures, including CO2 and pulsed-dye laser treatments, are gaining popularity in dermatology clinics due to their precision and faster healing profiles. This growing procedural volume and higher consumer preference for minimally invasive skin correction and at-home care options propel product demand across clinical and home care end use settings.
Telemedicine is a valuable resource in the management of scar wounds, facilitating the assessment, monitoring, and management of surgical and injury-related scarring remotely. Through teledermatology platforms and mobile applications, patients can upload high-resolution images of their scars or wounds and receive an assessment from a trained clinician with minimal face-to-face visits to the clinic. This strategy enhances access for patients in rural or underserved communities who lack proximate access to either a dermatologist or a plastic surgeon. For instance, an Italian-based study titled "Telemonitoring Wound Recovery with a Smartphone” concluded that a smartphone visit could produce similar outcomes to an in-person visit, while providing an enormous benefit by significantly reducing travel costs and time away from work and family that a face-to-face consultation creates.
The growing number of road accidents is one of the key factors, furthering the demand for scar treatment products. According to the Population Reference Bureau, around 50 million people are injured due to road accidents every year, which frequently leads to the occurrence of scars requiring surgical treatment. Patients who undergo such surgeries develop surgical scars and are provided with topical products to improve and reduce their appearance. Hence, the rising number of road accidents and an increasing number of cosmetic surgeries are expected to propel the need for topical products for scar treatment.
The high prevalence of burn injuries is another driving factor supporting the market's growth. According to the CDC, in the U.S., 1.1 million burn injuries require medical attention every year, and around 50,000 of these people require hospitalization. Burn injuries leave noticeable hypertrophic burn marks, which distort the victim's appearance. Scar removal products are crucial for such injuries. Moreover, post-burn marks hinder victims' routine lifestyles. Plastic surgeries or resurfacing laser therapies are commonly performed to remove these marks, accelerating the growth of scar removal treatment products.
The market is experiencing immense technological developments with the introduction of laser therapy, for instance, MedLite C6, a Q-switched laser-based instrument developed for treating acne. Laser instruments help destroy scar tissue, thereby driving the scar treatment product market. Treatment with laser products involves both surgical and nonsurgical procedures. Plastic and reconstructive surgery is also a part of the surgical laser treatment process. For instance, in April 2025, AVAVA received the U.S. Food and Drug Administration (FDA) 510(k) approval for the treatment of acne scarring across all Fitzpatrick skin types (I-VI). This approval addresses the long-standing challenge of safely treating acne scars in individuals with darker skin tones, expanding access to effective laser therapies, further driving the acne scar treatment market.
Global Scar Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends and opportunities in each sub-segment from 2021-2033. The report has segmented the global scar treatment market report based on product, scar type, end use, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Topical Products
- Laser Products
- Injectables
Scar Type Outlook (Revenue, USD Million, 2021-2033)
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Clinics
- Homecare
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Scar Treatment Market Variables, Trends & Scope
Chapter 4. Scar Treatment Market: Product Estimates & Trend Analysis
Chapter 5. Scar Treatment Market: Scar Type Estimates & Trend Analysis
Chapter 6. Scar Treatment Market: By End Use Estimates & Trend Analysis
Chapter 7. Scar Treatment Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Scar Treatment market report include:- Smith & Nephew PLC
- Lumenis
- Merz Pharmaceuticals, LLC
- Sonoma Pharmaceuticals, Inc.
- Cynosure
- CCA Industries, Inc.
- Newmedical Technology Inc.
- Mölnlycke Health Care AB
- Suneva Medical
- Scar Heal Inc.
- Pacific World Corporation
- Perrigo Company plc
- Enaltus LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | December 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 2.85 Billion |
| Forecasted Market Value ( USD | $ 6.45 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
